Location History:
- Deakin, AU (2019)
- McKellar, AU (2018 - 2020)
Company Filing History:
Years Active: 2018-2024
Title: Sudha Rao: Innovator in Cancer Therapy
Introduction
Sudha Rao is a prominent inventor based in McKellar, Australia. He has made significant contributions to the field of cancer therapy, holding a total of 6 patents. His work focuses on developing methods and agents that enhance the effectiveness of cancer treatments.
Latest Patents
One of Sudha Rao's latest patents is titled "Agents and methods for predicting response to therapy." This patent discloses methods and agents for predicting responses to therapy, particularly in detecting different forms of Programmed Death Ligand-1 (PD-L1) in cancer cells. These methods are useful for determining the location of PD-L1 within a cancer cell, predicting the likelihood of response to therapies such as immunotherapy, and managing treatment for cancer patients. Another significant patent is "Stem cell modulation II," which outlines methods and compositions for modulating cancer stem cells. This invention highlights the use of protein kinase C theta inhibitors for inhibiting the growth of cancer stem cells and enhancing the effects of chemotherapeutic drugs.
Career Highlights
Sudha Rao has worked with notable organizations, including Epiaxis Therapeutics Pty Ltd and the University of Canberra. His experience in these institutions has allowed him to advance his research and contribute to innovative cancer therapies.
Collaborations
Some of his coworkers include Anjum Zafar and Anjurn Zafar, who have collaborated with him on various projects related to cancer research.
Conclusion
Sudha Rao's innovative work in cancer therapy has the potential to significantly impact patient outcomes. His patents reflect a commitment to advancing medical science and improving treatment strategies for cancer patients.